According to a new report, published by KBV research, The Global Intraoperative Neuromonitoring Market size is expected to reach $7 billion by 2030, rising at a market growth of 6.0% CAGR during the forecast period.
The Insourced Monitoring segment is showcasing a CAGR of 5.5 % during the forecast period. Insourcing IONM allows for better integration of neuromonitoring into the overall surgical workflow. In-house teams can work closely with surgical staff, ensuring that monitoring is seamlessly incorporated into surgical procedures without disruptions. The insourced model allows for ongoing training and skill development of in-house neuromonitoring professionals. This ensures that the team remains proficient in the latest technologies and techniques, contributing to the overall competence of the monitoring services.
The Hospitals segment generated the highest revenue in the Global Intraoperative Neuromonitoring Market by End User in 2022; thereby, achieving a market value of $4.9 billion by 2030. Hospitals with specialized neurosurgery and orthopedic departments are major users of intraoperative neuromonitoring. These specialties, which frequently involve surgeries near critical neural structures, rely on IONM to enhance safety and improve patient outcomes. Hospitals prioritize patient safety and the delivery of high-quality care. Intraoperative neuromonitoring contributes to these goals by providing a proactive approach to preventing neurological complications during surgery, ensuring the well-being of patients undergoing various procedures.
The Services segment is registering a CAGR of 5.6 % during the forecast period. Services in IONM involve real-time monitoring of the patient's nervous system during surgery. Neurophysiologists and neurologists provide continuous feedback to the surgical team, enabling immediate intervention if any potential nerve damage is detected. Service providers tailor monitoring protocols based on the specific type of surgery and the patient's medical history. The services segment involves training and educating healthcare professionals on properly using and interpreting intraoperative neuromonitoring data.
The Spinal Surgery segment led the Global Intraoperative Neuromonitoring Market by Application in 2022; thereby, achieving a market value of $1.9 billion by 2030. The rising incidence of spinal disorders, including degenerative conditions, spinal tumors, and deformities, has led to an increased number of spinal surgeries. As the volume of spinal surgeries grows, so does the demand for intraoperative neuromonitoring to safeguard neural structures during these procedures. Spinal surgeries involve proximity to critical neural structures, including the spinal cord and nerve roots. Intraoperative neuromonitoring serves as a risk mitigation tool, enabling the early detection of changes in neural function and allowing surgeons to adjust their approach promptly to prevent potential complications.
The Electromyography (EMG) segment is growing at a CAGR of 4.3 % during the forecast period. EMG allows for the continuous monitoring of nerve integrity during surgery. Surgeons can assess the electrical activity of muscles innervated by specific nerves, helping to identify potential nerve damage, and allowing for immediate intervention. EMG helps detect nerve compression or tension early, allowing surgeons to address these issues promptly. This proactive approach helps prevent complications and reduces the risk of postoperative nerve dysfunction.
Full Report: https://www.kbvresearch.com/intraoperative-neuromonitoring-market/
The North America region dominated the Global Intraoperative Neuromonitoring Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2.6 billion by 2030. The Europe region is anticipated to grow at a CAGR of 5.6% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 6.9% during (2023 - 2030).
By Source Type
By End User
By Products & Services
By Application
By Modality
Unique Offerings 
